De Jong M, Docter R, Bernard B F, van der Heijden J T, van Toor H, Krenning E P, Hennemann G
Department of Internal Medicine III, Erasmus University Rotterdam, The Netherlands.
Am J Physiol. 1994 May;266(5 Pt 1):E768-75. doi: 10.1152/ajpendo.1994.266.5.E768.
Recently, we described a two-pool model for 3,5,3'-triiodothyronine uptake and metabolism in the isolated perfused rat liver. Here, we applied this model to investigate transmembrane thyroxine (T4) transport and its possible ATP dependence in vivo. These studies are performed in perfused rat livers during perfusion with or without fructose in the medium, as it has been shown that intracellular ATP is decreased after fructose loading. Furthermore, we studied serum T4 tracer disappearance curves in four human subjects before and after intravenous fructose loading. In the perfused rat liver, we found a decrease in liver ATP concentration and a decrease in medium T4 disappearance and T4 uptake in the liver pool after fructose. Furthermore, it was shown that, when corrected for differences in the medium free hormone concentration, only transport to the metabolizing liver pool was decreased after fructose perfusion, whereas uptake in the nonmetabolizing pool was unaffected. Disposal, corrected for differences in transport into the metabolizing pool, was also not affected after fructose. In the human studies, intravenous fructose administration induced a rise in serum lactic acid and uric acid, indicating a decrease in liver ATP. This was observed concomitant with a decrease in serum tracer T4 disappearance during the first 3 h after fructose administration. These results suggest ATP dependence of transport of iodothyronines into the liver in vivo and show that, in the rat liver and in humans, uptake of T4 may be regulated by intracellular energy stores; in this way the tissue uptake process may affect intracellular metabolism and bioavailability of thyroid hormone.
最近,我们描述了一个用于研究3,5,3'-三碘甲状腺原氨酸在离体灌注大鼠肝脏中摄取和代谢的双池模型。在此,我们应用该模型来研究甲状腺素(T4)在体内的跨膜转运及其可能的ATP依赖性。这些研究在灌注有或没有在培养基中添加果糖的大鼠肝脏中进行,因为已经表明果糖负荷后细胞内ATP会降低。此外,我们研究了四名人类受试者在静脉注射果糖负荷前后血清T4示踪剂消失曲线。在灌注的大鼠肝脏中,我们发现果糖处理后肝脏ATP浓度降低,培养基中T4消失以及肝脏池中T4摄取减少。此外,结果表明,校正培养基中游离激素浓度的差异后,果糖灌注后仅转运至代谢性肝脏池减少,而非代谢性池中摄取不受影响。校正转运至代谢性池的差异后,果糖处理后的处置也未受影响。在人体研究中,静脉注射果糖导致血清乳酸和尿酸升高,表明肝脏ATP降低。这与果糖给药后最初3小时内血清示踪剂T4消失减少同时出现。这些结果表明碘甲状腺原氨酸在体内转运至肝脏具有ATP依赖性,并表明在大鼠肝脏和人类中,T4的摄取可能受细胞内能量储备调节;通过这种方式,组织摄取过程可能会影响甲状腺激素的细胞内代谢和生物利用度。